Your Breast Cancer Risk


Play Video
90% of breast cancer is not hereditary.
This is where a new type of genetic test comes in: individualized genetic risk assessment.
Predict Your Risk

Introducing the Premier Home Test Kit for genetic risk assessment:

Determine your personal likelihood of developing breast cancer

over the next 5 years & lifetime

with a combined clinical & genetic risk assessment test derived

from up to 200 genetic markers, including all racial variables for disease.

All with a simple, easy-to-use cheek swab

from the comfort of your home.

See what the experts say:

Limited Time Offer: Save $150

Get the geneType Breast Cancer Risk Assessment Test Kit

including a one-on-one personalized genetic counseling session

FOR JUST $149!

That's $150 off the regular price of $299, but only for a limited time!

You Will Receive a
Clear, Easy To Understand Report

And a Personal, one-on-one appointment with

geneType’s Genetic Counselors

That's a cutting-edge lab test & a visit to a specialist

All for $149

Get in Touch

Have a question about our geneType Breast Cancer Test or other services? Fill out the form below and our team will be in touch.

Accredited For Compliance With NPAAC Standards And ISO 15189
CLIA Number 99D2023356

geneType logo

1. American Cancer Society. URL: https://www.cancer.org/cancer/breast-cancer/understanding-a-breast-cancer-diagnosis/breast-cancer-survival-rates.html 2. van der Groep P et al. Cell Oncol (Dordr) 2011;34:71 -88. 3. Dite GS et al. Cancer Epidemiol Biomarkers Prev 2016;25:359 -65. 4. Allman R, et al. SNPs and breast cancer risk prediction for African American and Hispanic women. Breast Cancer Res Treat. 2015 Dec;154(3):583-9. 5. Spaeth E, et al. Validation of abridged breast cancer risk assessment model for the general population [abstract]. In: Proceedings of the 2021 San Antonio Breast Cancer Symposium; 2021 Dec 7-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2022;82(4 Suppl):Abstract nr P2-10-06.. 6. Medication Use to Reduce Risk of Breast Cancer, United States Preventative Services Task Force. JAMA. 2019; 322(9):857-867 7. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines); Breast Cancer Screening and Diagnosis. Version 1.2021- April 2022. 8. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines); Breast Cancer Risk Reduction. Version 1.2022 – April 2022 9. Use of Endocrine Therapy for Breast Cancer Risk Reduction. Journal of Clinical Oncology 37, no. 33 (November 20, 2019) 3152-3165. 10. Monticciolo D et al. Breast Cancer Screening Recommendations Inclusive of All Women at Average Risk: Update from the ACR and Society of Breast Imaging. J Am Coll Radiol. 2021 Sep;18(9):1280-1288.

Skip to content